The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Cross Talk Between Endothelial and Smooth Muscle Cells in Pulmonary Hypertension: Critical Role for Serotonin-Induced Smooth Muscle Hyperplasia
Abstract
Background— The mechanism of pulmonary artery smooth muscle cell (PA-SMC) hyperplasia in idiopathic pulmonary artery hypertension (iPH) may involve both an inherent characteristic of PA-SMCs and abnormal control by external stimuli. We investigated the role of pulmonary microvascular endothelial cells (P-ECs) in controlling PA-SMC growth. Methods and Results— Serum-free medium of quiescent P-ECs elicited marked PA-SMC proliferation, and this effect was greater with P-ECs from patients with iPH than from control subjects and greater with PA-SMCs from these patients than from control subjects. Fluoxetine, which inhibits serotonin-induced mitogenesis by blocking the serotonin transporter, and p-chlorophenylalanine, which inhibits serotonin synthesis by blocking tryptophan hydroxylase (TPH), caused a similar 60% reduction in the growth-promoting effect of P-EC media, whereas endothelin receptor blockers had no effect. Assays of TPH activity in P-EC medium based on p-chlorophenylalanine–sensitive 5-hydroxytryptophan accumulation or serotonin determination indicated serotonin synthesis by P-ECs and an increase in this TPH-dependent process in iPH. Expression of the tph1 gene encoding the peripheral form of the TPH enzyme was increased in lungs and P-ECs from patients with iPH. Lung TPH1 immunostaining was confined to the pulmonary vessel intima. Conclusions— P-ECs produce paracrine factors governing PA-SMC growth. Serotonin, the main P-EC–derived growth factor, is overproduced in iPH and contributes to PA-SMC hyperplasia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Endothelial/Pericyte Interactions
Armulik, A., Abramsson, A., & Betsholtz, C. (2005) · Circulation Research · doi:10.1161/01.res.0000182903.16652.d7 · Cited by 2,048
Expression of Endothelin-1 in the Lungs of Patients with Pulmonary Hypertension
Giaid, A., Yanagisawa, M., Langleben, D., Michel, R. P., Levy, R., Shennib, H., Kimura, S., Masaki, T., Duguid, W. P., & Stewart, D. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306173282402 · Cited by 1,842
p-CHLOROPHENYLALANINE: A SPECIFIC DEPLETOR OF BRAIN SEROTONIN
Koe, B. K., & Weissman, A. (1966) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)27497-3 · Cited by 1,783
Synthesis of Serotonin by a Second Tryptophan Hydroxylase Isoform
Walther, D. J., Peter, J.-U., Bashammakh, S., Hörtnagl, H., Voits, M., Fink, H., & Bader, M. (2003) · Science · doi:10.1126/science.1078197 · Cited by 1,570
Pulmonary Arterial Hypertension
Farber, H. W., & Loscalzo, J. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035488 · Cited by 1,463
Giaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Blood Vessel Formation: What Is Its Molecular Basis?
Folkman, J., & D'Amore, P. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81810-3 · Cited by 1,215
Signaling Vascular Morphogenesis and Maintenance
Hanahan, D. (1997) · Science · doi:10.1126/science.277.5322.48 · Cited by 1,190
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Self-citationTUDER, R. M., COOL, C. D., GERACI, M. W., WANG, J., ABMAN, S. H., WRIGHT, L., BADESCH, D., & VOELKEL, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 806
Eddahibi, S., Humbert, M. J. C., Fadel, É., Raffestin, B., Darmon, M. C., Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., & Adnot, S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12805 · Cited by 579
Self-citationAppetite-suppressant drugs and the risk of primary pulmonary hypertension
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562
Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel
Gershon, M. D. (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00002.x-i2 · Cited by 466
Morrell, N. W., Yang, X., Upton, P. D., Jourdan, K. B., Morgan, N., Sheares, K. K., & Trembath, R. C. (2001) · Circulation · doi:10.1161/hc3201.094152 · Cited by 453
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension
Launay, J.-M., Hervé, P., Peoc'h, K., Tournois, C., Callebert, J., Nebigil, C. G., Etienne, N., Drouet, L., Humbert, M., Simonneau, G., et al. (2002) · Nature Medicine · doi:10.1038/nm764 · Cited by 433
Self-citationYu, Y., Fantozzi, I., Remillard, C. V., Landsberg, J. W., Kunichika, N., Platoshyn, O., Tigno, D. D., Thistlethwaite, P. A., Rubin, L. J., & Yuan, J. X.-J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405908101 · Cited by 430
Stimulation of aortic smooth muscle cell mitogenesis by serotonin.
Nemecek, G. M., Coughlin, S. R., Handley, D. A., & Moskowitz, M. A. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.3.674 · Cited by 332
ET A and ET B Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells
DAVIE, N., HALEEN, S. J., UPTON, P. D., POLAK, J. M., YACOUB, M. H., MORRELL, N. W., & WHARTON, J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.3.2104059 · Cited by 314
A new role for an old molecule: serotonin as a mitogen
Fanburg, B. L., & Lee, S. L. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.5.l795 · Cited by 255
Eddahibi, S., Fabre, V., Boni, C., Martres, M. P., Raffestin, B., Hamon, M., & Adnot, S. (1999) · Circulation Research · doi:10.1161/01.res.84.3.329 · Cited by 213
Self-citationHamon, M., Fattaccini, C. M., Adrien, J., Gallissot, M. C., Martin, P., & Gozlan, H. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22158-9 · Cited by 206
Self-citationSerotonin-Induced Smooth Muscle Hyperplasia in Various Forms of Human Pulmonary Hypertension
Marcos, E., Fadel, E., Sanchez, O., Humbert, M., Dartevelle, P., Simonneau, G., Hamon, M., Adnot, S., & Eddahibi, S. (2004) · Circulation Research · doi:10.1161/01.res.0000126847.27660.69 · Cited by 195
Self-citationInduction of pulmonary hypertension by an angiopoietin 1/TIE2/serotonin pathway
Sullivan, C. C., Du, L., Chu, D., Cho, A. J., Kido, M., Wolf, P. L., Jamieson, S. W., & Thistlethwaite, P. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933740100 · Cited by 174
Factors Influencing the Idiopathic Development of Pulmonary Hypertension in the Fawn Hooded Rat
Sato, K., Webb, S. A., Tucker, A., Rabinovitch, M., OʼBrien, R. F., McMurtry, I. F., & Stelzner, T. J. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.793 · Cited by 167
Dual effect of serotonin on growth of bovine pulmonary artery smooth muscle cells in culture.
Lee, S. L., Wang, W. W., Moore, B. J., & Fanburg, B. L. (1991) · Circulation Research · doi:10.1161/01.res.68.5.1362 · Cited by 156
Human microvessel endothelial cells: Isolation, culture and characterization
Hewett, P. W., & Murray, J. C. (1993) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/bf02631356 · Cited by 107
Clinical economics review: medical management of inflammatory bowel disease
WARD, Bodger, K., DALY, & Heatley (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00437.x · Cited by 105
The Human Tryptophan Hydroxylase Gene
Boularand, S., Darmon, M. C., & Mallet, J. J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3748 · Cited by 69
Lessons learned from cancer may help in the treatment of pulmonary hypertension
Adnot, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25399 · Cited by 54
Self-citationTappaz, M., & Pujol, J. (1980) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1980.tb09668.x · Cited by 51
Lepetit, P., Touret, M., Grange, E., Gay, N., & Bobillier, P. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90171-l · Cited by 19
Primary Pulmonary Hypertension and Anorectic Drugs
Louis, W. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400614 · Cited by 17
Cited by
Phenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,257
Cellular and Molecular Basis of Pulmonary Arterial Hypertension
Morrell, N. W., Adnot, S., Archer, S. L., Dupuis, J., Lloyd Jones, P., MacLean, M. R., McMurtry, I. F., Stenmark, K. R., Thistlethwaite, P. A., Weissmann, N., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.018 · Cited by 819
Self-citationMechanisms of disease: pulmonary arterial hypertension
Schermuly, R. T., Ghofrani, H. A., Wilkins, M. R., & Grimminger, F. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.87 · Cited by 800
Pulmonary Arterial Hypertension
McLaughlin, V. V., & McGoon, M. D. (2006) · Circulation · doi:10.1161/circulationaha.104.503540 · Cited by 664
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Metadata
- Authors
- Eddahibi, S., Guignabert, C., Barlier-Mur, A.-M., Dewachter, L., Fadel, E., Dartevelle, P., Humbert, M., Simonneau, G., Hanoun, N., Saurini, F., Hamon, M., & Adnot, S.
- Venue
- Circulation
- Published
- 2006-04-18
- Volume
- 113
- Issue
- 15
- Pages
- 1857-1864
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2108805152
- Cited by
- 297
- References
- 33
- FWCI
- 13.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.